Chemicals - Speciality Stocks in India

4-Factor Sector Score

An additive sector-relative research score. The four displayed point contributions always equal the total: Growth & earnings (35), Capital efficiency (25), Valuation (20), and Relative strength (20). Missing or stale evidence is absorbed inside the affected factor, never applied as a hidden adjustment.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is guarded: positive earnings, positive 5–60% three-year EPS growth, and a positive P/E are required.

Revenue Scale & Growth Durability

Jubilant Agri & Consumer Products Ltd has the highest Revenue among the 5 Chemicals - Speciality companies compared here, at ₹1,891 crore. Sudeep Pharma Ltd is next at ₹642 crore. Anlon Healthcare Ltd has the highest Revenue growth at 43.3%, so level and change sit with different companies. Its Revenue series carries 10 reported observations across the 20-quarter window.

What the numbers say: Jubilant Agri & Consumer Products Ltd is the scale leader at ₹1,891 crore, 194.5% ahead of Sudeep Pharma Ltd. Anlon Healthcare Ltd's growth is 43.3% from a ₹173 crore base, with 8 reported observations in the 20-quarter window. Treat the growth leader as an acceleration candidate, not as equally proven scale.

Investor read: Jubilant Agri & Consumer Products Ltd is the scale benchmark; Anlon Healthcare Ltd is the acceleration watch. Promote the challenger only if growth persists and converts into margin and returns.

This conclusion weakens if: Jubilant Agri & Consumer Products Ltd's growth falls below Anlon Healthcare Ltd's for two consecutive comparable reports while operating margin also compresses.

Operating Economics & Margin Trend

Sudeep Pharma Ltd has the highest OPM among the 5 Chemicals - Speciality companies compared here, at 34%. Anlon Healthcare Ltd is next at 30%. Chembond Chemicals Ltd has the highest Margin change at +0.2 percentage points, so level and change sit with different companies. 4 of 5 companies report a comparable reading, the latest through Mar 2026.

What the numbers say: Sudeep Pharma Ltd leads opm at 34%; Chembond Chemicals Ltd leads margin change at +0.2 percentage points.

Investor read: Sudeep Pharma Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current margin change signal.

Profit Scale & Acceleration

Sudeep Pharma Ltd has the highest Net profit among the 5 Chemicals - Speciality companies compared here, at ₹175 crore. Jubilant Agri & Consumer Products Ltd is next at ₹128 crore. Jubilant Agri & Consumer Products Ltd has the highest Profit growth at 45.5%, so level and change sit with different companies.

What the numbers say: Sudeep Pharma Ltd leads with ₹175 crore of TTM profit, 36.7% above Jubilant Agri & Consumer Products Ltd. Jubilant Agri & Consumer Products Ltd shows 45.5% growth from a ₹128 crore profit base. Compare the size of the base and persistence before ranking acceleration above profit scale.

Investor read: Sudeep Pharma Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current profit growth signal.

Capacity Spending & Returns On It

Sudeep Pharma Ltd has the highest CAPEX among the 5 Chemicals - Speciality companies compared here, at ₹14 crore. Anlon Healthcare Ltd is next at ₹0 crore. The same company also holds the highest CAPEX intensity, at 8.6%. 2 of 5 companies report a comparable reading, the latest through Mar 2026.

What the numbers say: Sudeep Pharma Ltd reports ₹14 crore of CAPEX; Sudeep Pharma Ltd has the highest covered intensity at 8.6%. Coverage is only 2 of 5 companies and 8 reported observations, so this is partial evidence—not a complete sector rank.

Investor read: Use the CAPEX rank as a diligence queue. Verify commissioning, utilization, cash conversion and post-investment ROCE before treating spend as value creation.

This conclusion weakens if: CAPEX rises without higher utilization, operating cash flow or incremental returns.

Debt Load & Balance-Sheet Headroom

Chembond Chemicals Ltd has the lowest Gross debt among the 5 Chemicals - Speciality companies compared here, at ₹0 crore. Innovassynth Technologies (India) Ltd is next at ₹5 crore. The same company also holds the lowest Net debt, at ₹52 crore net cash. 5 of 5 companies report a comparable reading, the latest through Jun 2026.

What the numbers say: Chembond Chemicals Ltd has the clearest covered balance-sheet capacity with ₹52 crore net cash and gross debt of ₹0 crore. Absolute debt alone does not identify the strongest balance sheet because company scale differs; net debt and debt-to-equity carry more information.

Investor read: Prioritize net-cash capacity and leverage relative to operating scale, not the smallest absolute rupee debt.

This conclusion weakens if: Net debt rises faster than revenue and profit for two consecutive reported periods.

Return On Capital Employed

Jubilant Agri & Consumer Products Ltd has the highest ROCE among the 5 Chemicals - Speciality companies compared here, at 39.9%. Sudeep Pharma Ltd is next at 28.2%. The same company also holds the highest ROCE change, at +0.1 percentage points. 5 of 5 companies report a comparable reading, the latest through Mar 2026.

What the numbers say: Jubilant Agri & Consumer Products Ltd leads ROCE at 39.9%, 11.7 percentage points above Sudeep Pharma Ltd. Jubilant Agri & Consumer Products Ltd has the strongest latest improvement at +0.1 percentage points. Read the leader beside the density of its reported history: a sparse high return is a candidate; a repeated high return is evidence of durability.

Investor read: Jubilant Agri & Consumer Products Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current roce change signal.

Valuation Against Growth & Quality

Jubilant Agri & Consumer Products Ltd has the lowest Guarded PEG among the 5 Chemicals - Speciality companies compared here, at 0.79×. Sudeep Pharma Ltd is next at 4.75×. Chembond Chemicals Ltd has the lowest P/E at 17.4×, so level and change sit with different companies. 2 of 5 companies report a comparable reading, the latest through Mar 2026.

What the numbers say: Jubilant Agri & Consumer Products Ltd has the lowest comparable Guarded PEG at 0.79×, 83.4% below Sudeep Pharma Ltd. Only 2 of 5 companies pass the guard, so no broad “cheapest stock” conclusion is defensible unless the current multiple, own-history position and growth durability agree.

Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.

This conclusion weakens if: The next two comparable reports reverse the current p/e signal.

Enterprise Value & Book Value

Chembond Chemicals Ltd has the lowest EV/EBITDA among the 5 Chemicals - Speciality companies compared here, at 10.9×. Jubilant Agri & Consumer Products Ltd is next at 12.2×. The same company also holds the lowest P/BV, at 3.21×. 4 of 5 companies report a comparable reading, the latest through Jun 2026.

What the numbers say: Chembond Chemicals Ltd leads both ev/ebitda at 10.9× and p/bv at 3.21×.

Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.

This conclusion weakens if: The next two comparable reports reverse the current p/bv signal.

Market action

Jubilant Agri & Consumer Products Ltd has the strongest one-year price move in Chemicals - Speciality at +1.8%. Innovassynth Technologies (India) Ltd leads on Mansfield relative strength against NIFTY at +59.2%. 2 of 3 covered companies are above zero on that measure. Every line covers 313 weekly closes through 2026-07-17.

What can make this comparison misleading?

This Chemicals - Speciality comparison names 7 specific ways its own evidence can mislead, all listed below. 1 of the 5 companies reports on an older date than the sector's freshest reporters, so its rank is marked stale. 2 draw at least one figure from a second feed with too little overlap to cross-check.

Which companies are included?

All 5 companies in the canonical Chemicals - Speciality membership are listed below, largest market value first — nothing is silently dropped, even where a company reports too little to rank. The charts above default to a selective view; this register is the complete set, with each company's own latest reporting date beside it.

AHEAD means the company is beating the index by 5% or more over three months. LAGGING, FUNDAMENTALS UP means it is 20% or more behind over a year while its trailing twelve-month earnings grew 20% or more. Both rules are fixed and applied the same way in every sector.

How was this comparison built?

This comparison is built from the reported filings of 5 Chemicals - Speciality companies, normalized to a common ₹ scale and a shared quarter axis of up to 20 quarters each. Fundamentals run through Jun 2026 and market data through 2026-07-24. A second data feed fills gaps only after identity and scale reconciliation, and missing observations are never interpolated.

A second feed is read only after its reported income is matched against the primary source on at least three overlapping periods. Where the two agree the figures fill silently. Where there is too little shared history to compare, the figures are still drawn — they are the only evidence there is — and marked ⚠ unverified everywhere they appear. Where the two are known to disagree, nothing from the second feed is drawn and the affected company is named under the chart it is missing from. Every company's standing is listed in the register above.

Chemicals - Speciality company comparison FAQs

These 17 answers restate the Chemicals - Speciality comparison above in question form. Every one is computed from the same 5 companies and the same reported filings as the rankings and charts, current through Jun 2026. Price and relative-strength answers run through 2026-07-24. Nothing here is estimated, and none of it is a recommendation.